Restore a newborn's gut microbiota using the mother's microbes.
Official title: Infant Microbiota Restoration With Maternal Microbes
Run by University of Helsinki · NCT07212361 · Data updated 2026-11-12
This will test whether giving C-section newborns bacteria from their own mother or commercial probiotics helps their gut microbiota become more like babies born vaginally.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | Any age to 50 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University of Helsinki Academic / other |
| Locations | 2 sites (Helsinki and 1 other locations) |
| Status | Recruiting |
| Started | July 17, 2025 |
| Main results expected | December 31, 2035 |
| Study ends | December 31, 2035 |
| Registry record updated | October 8, 2025 |
| Trial ID | NCT07212361 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are healthy full-term infants born by planned cesarean whose mothers are healthy, speak Finnish or Swedish, plan to provide breastmilk, and live within about a two-hour drive of Meilahti, Helsinki.
✕Probably not a fit
Infants born prematurely, those who receive antibiotics in the first week, those with major congenital anomalies or low Apgar scores, or infants of mothers with pregnancy complications are unlikely to qualify or benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The trial compares selective maternal-derived bacterial products, a commercial probiotic, and placebo to restore gut microbiota in infants born by cesarean section. Infants receive an oral bacterial product once daily for either one or four weeks and parents collect fecal, urine, and saliva samples for microbiome and safety analysis. Treated C-section infants are compared to untreated C-section infants and to vaginally born infants to determine whether the treatments make the microbiota resemble that of vaginally born babies. The project is led by the Faculty of Medicine at the University of Helsinki and conducted at Helsinki University Hospital.
Why it matters
Potential benefit: If successful, this could restore a more natural infant microbiome and potentially reduce long-term health risks associated with cesarean-related microbiota disturbances.
How similar studies have gone: Previous small studies using maternal fecal microbiota transplant have shown promising restoration of C-section infant microbiota, but selective maternal-derived products are a newer, less-tested approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Healthy mother and healthy pregnancy * Singleton pregnancy, * Mothers who speak Finnish or Swedish * Mothers who are planning to breastfeed or give breastmilk by bottle to the infant * Infants who are expected to be healthy and who will not require BCG vaccination. Exclusion Criteria: * Participants who lives further than a 2-hour drive from Meilahti, Helsinki, Finland * Mothers who are not planning to breastfeed or feed breastmilk by bottle to the infant * Mothers who are diagnosed with gestational diabetes, pre-eclampsia or who have been receiving antibiotics during the pregnancy or delivery * Premature infants born before the pregnancy week 37 * Infants, who are born by urgent cesarean section or emergency cesarean section * Infants, who receive antibiotics during the first week of life * Infants, who are diagnosed with a disease, congenital anomaly or who receive less than 9 Apgar points at 5 minutes. * Infants, who receive BCG-vaccine
Where it's running
-
Helsinki University Hospital
Helsinki, Finland Recruiting -
University of Helsinki
Helsinki, Finland Recruiting
Study contacts
- Study coordinator: Katri E Korpela, PhD
- Email: katri.korpela@helsinki.fi
- Phone: +358504486369
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Support for Just-In-Time Consent for Prenatal Screening
This study tests a short set of information cards delivered on a phone to help pregnant people decide about prenatal screening.
-
How information about planned labor induction affects childbirth experience
This project will see if being well informed about a planned induction of labor and patterns of social media use change the childbirth experience for people having a scheduled induction.
-
Coenzyme Q10 toothpaste with daily Limosilactobacillus reuteri probiotics to improve gum health during pregnancy
For pregnant women with gum disease, this will try whether adding a CoQ10 toothpaste and daily L. reuteri probiotic to regular cleanings reduces plaque and gum bleeding.
-
Health of women with cystic fibrosis during pregnancy and their young children
This project will follow women with cystic fibrosis who are planning pregnancy, pregnant, or new parents, and their babies to see how pregnancy and current CF treatments affect maternal physical and mental health and early child health.
-
Comparing two devices for inducing labor in women with a previous C-section
This study is testing two devices to see which one helps women who had a previous C-section have a quicker and safer labor.
-
Exploring how doulas help people with perinatal mood and anxiety disorders
This study is testing whether having a specially trained doula can help people dealing with mood and anxiety issues during and after pregnancy feel better.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.